Achieve Life Sciences, Inc.

NASDAQ:ACHV

Biotechnology

Healthcare
$6.78 -7.00%

-$0.38 today

Market cap
$697.68M
Beta
2.26
P/E (TTM)
-5.1
EPS (TTM)
-$0.97
52W Low $2.00High $6.16

Volume 1.09M

Average 1.44M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$54.88M

FY 2025 · Annual

Net Income

-$54.65M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue000229K228K
Gross Profit000(229K)(228K)
Gross Margin—————
Research & Development23.97M30.08M15.81M22.82M22.96M
Selling, General & Admin9.13M10.72M11.44M16.25M31.87M
Operating Expenses33.09M40.8M27.25M38.84M54.65M
Depreciation & Amortization250K236K228K229K228K
EBITDA(32.9M)(40.33M)(26.73M)(37.42M)(53.6M)
EBITDA Margin—————
Operating Income(33.09M)(40.8M)(27.25M)(39.07M)(54.88M)
Operating Margin—————
Interest Income17K199K825K2.36M1.5M
Interest Expense01.79M2.85M2.18M819K
Other Income / Expenses(58K)(1.55M)(2.57M)(758K)232K
Income Before Tax(33.15M)(42.35M)(29.82M)(39.83M)(54.65M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(33.15M)(42.35M)(29.82M)(39.83M)(54.65M)
Net Margin—————
EPS (Basic)(4.05)(3.95)(1.50)(1.24)(1.25)
EPS (Diluted)(4.05)(3.95)(1.50)(1.24)(1.25)
Weighted Avg Shares8.12M10.59M19.83M32.07M43.59M
Weighted Avg Shares (Diluted)8.12M10.59M19.83M32.07M43.59M

ACHV Earnings Waterfall · TTM

NASDAQ:ACHV · Revenue to Net Income

Key Ratios

EPS$-1.12
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-3.2
P/S Ratio0.0

Analysis

$0 of revenue converted into -$52.0M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.12, tying the income statement back to per-share earnings.

Competitors

Peer companies in the same sector

Health

No competitor data available.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
3Initial statement of beneficial ownershipOct 6, 2026
4Statement of changes in beneficial ownershipOct 6, 2026
8-KCurrent reportOct 1, 2026
4Statement of changes in beneficial ownershipAug 21, 2026
SC 13GSC 13G filingAug 17, 2026

How much revenue does ACHV generate?

Achieve Life Sciences, Inc. (ACHV) reported $0.00 of revenue in fiscal 2025.

Is ACHV profitable?

Achieve Life Sciences, Inc. (ACHV) reported -$54.65M of net income.